United Health Products Inc. Receives Initial HemoStyp® Order for Australian Market
December 19 2013 - 8:31AM
Business Wire
Receives Australian Regulatory
Approval
United Health Products, Inc. (OTCQB:UEEC) announced that its
Australian distributor, Critical Health Products Ltd., has placed
an initial order for HemoStyp® gauze products. The order was placed
following Critical Health Products’ notification that HemoStyp has
been granted TGA (Therapeutic Goods Administration) approval. The
TGA is a Commonwealth Government agency that regulates medical
devices and drugs in Australia.
This initial stocking order will be followed by quarterly
product orders in 2014, each expected to exceed $250,000 as
Critical Health Products launches its sales campaign.
Ian French, President of Critical Health Products, stated, “Our
initial focus will be in Western Australia, targeting first
responders, surgery centers and medical communities. Our
distributor, Westcoast Surgical and Medical Supplies (a subsidiary
of the international distribution network SUDA Pty Ltd.
http://www.sudaltd.com.au/index.php/west-coast-surgical-a-u) has
existing supply contracts in multiple markets, including:
- Public and private hospitals, aged
care, defense, police and emergency services, state and federal
government agencies including jails and detention centers, chemist
and dental outlets and veterinary.”
Westcoast Surgical and Medical (www.westcoastsurgical.com.au/)
will market to existing customers.
- The company will subsequently tap into
its management’s extensive experience and relationships with the
Australian Armed Forces.
- Critical Health Products intends to
work with these parties and groups in similar business segments in
each of its licensed geographic areas (Australia, Oceania, and
South East Asia).
Douglas Beplate, COO of United Health Products, added, “We have
laid an initial foundation with recently executed agreements with
our first three distributor/partners (dental, US military +
worldwide equestrian, and Australasia) and look forward to
expanding on that base when we enter the international dialysis
market in 2014.”
HemoStyp - Benefits
HemoStyp is an all-natural product comprised of regenerated
oxidized cellulose gauze which is specifically formulated to aid in
the process of hemostasis (clotting) when positioned on a cut or
wound.
- HemoStyp stops bleeding faster than
ordinary gauze and is a more effective alternative;
- Unlike the other products in the wound
care market, HemoStyp contains no potentially harmful chemicals or
animal byproducts and is hypoallergenic;
- Once it has completed its task,
HemoStyp gauze is easily removed by dissolving it in water or
saline solution. This method of removal neither disturbs the
clotted surface nor encourages re-bleeding.
About Critical Health Products Ltd.
Critical Health Products, an Australian-based company with
principle offices in Marmion, WA, is the exclusive HemoStyp
products sales and distribution partner for Australia, and the
countries of Oceania, and South East Asia (excluding the equestrian
market). For more information, contact:
ianfrench@hemostyp.com.au
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and
markets a patented HemoStypTM hemostatic gauze for the healthcare
and wound care sectors. HemoStyp is derived from regenerated
oxidized cellulose, which is all natural, and designed to absorb
exudate/drainage from superficial wounds and helps control
bleeding. UEEC is focused on identifying new markets and
applications for its product as well as ramping up sales in its
current markets. For more on United Health Products, Inc.
visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release may contain forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking
statements.
Company:United Health Products, Inc.Douglas Beplate,
COO877-358-3444d.beplate@unitedhealthproductsinc.comorIR:Bibicoff
+ MacInnis, Inc.Terri MacInnis, Dir. of
IR818-379-8500terri@bibimac.com
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
United Health Products (PK) (USOTC:UEEC)
Historical Stock Chart
From Apr 2023 to Apr 2024